CHEK2 and breast cancer: In summary, we provide compelling evidence demonstrating that TAIII induces cell cycle arrest and apoptosis through ATM/Chk2 and p38 MAPK signaling pathways, associating with induction of DNA damage, which offer a promising anti-tumor agent against breast cancer.